口服胆骨化醇对维生素D不充足的慢性创面患者创面愈合的影响

注册号:

Registration number:

ChiCTR2200065482 

最近更新日期:

Date of Last Refreshed on:

2023-04-28 08:37:34 

注册时间:

Date of Registration:

2022-11-06 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

口服胆骨化醇对维生素D不充足的慢性创面患者创面愈合的影响

Public title:

Impact of oral vitamin D in chronic wound patients with Vitamin D Deficiency

注册题目简写:

English Acronym:

研究课题的正式科学名称:

口服胆骨化醇对维生素D不充足的慢性创面患者创面愈合的影响

Scientific title:

Impact of oral vitamin D in chronic wound patients with Vitamin D Deficiency

研究课题代号(代码):

Study subject ID:

AF/SC-08/01.4

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

吴小堃 

研究负责人:

吴小堃/李海燕 

Applicant:

Xiaokun Wu 

Study leader:

Xiaokun Wu/Haiyan Li 

申请注册联系人电话:

Applicant telephone:

+86 13068695785

研究负责人电话:

Study leader's
telephone:

+86 13068695785

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wuxk@gdpu.email.cn

研究负责人电子邮件:

Study leader's E-mail:

wuxk@gdpu.email.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市海珠区江海大道283号

研究负责人通讯地址:

广东省广州市海珠区江海大道283号/广东省广州市海珠区同福中路396号

Applicant address:

283 Jianghai Avenue, Haizhu District, Guangzhou, Guangdong

Study leader's address:

283 Jianghai Avenue, Haizhu District, Guangzhou, Guangdong

申请注册联系人邮政编码:

Applicant postcode:

510315

研究负责人邮政编码:

Study leader's postcode:

510315

申请人所在单位:

广东药科大学

Applicant's institution:

Guangdong Pharmaceutical University

研究负责人所在单位:

广州市红十字会医院

Affiliation of the Leader:

Guangzhou Red Cross Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

穗红医院伦审2022-219-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广州市红十字会医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Guangzhou Red Cross Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2022-09-23 00:00:00

伦理委员会联系人:

邝莹

Contact Name of the ethic committee:

Ying Kuang

伦理委员会联系地址:

广东省广州市海珠区同福中路396号

Contact Address of the ethic committee:

396 Tongfu Road Middle, Haizhu District, Guangzhou, Guangdong

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 61883974

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广州市红十字会医院

Primary sponsor:

Guangzhou Red Cross Hospital

研究实施负责(组长)单位地址:

广东省广州市海珠区同福中路396号

Primary sponsor's address:

396 Tongfu Road Middle, Haizhu District, Guangzhou, Guangdong

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州市红十字会

具体地址:

海珠区同福中路396号

Institution
hospital:

Guangzhou Red Cross Hospital

Address:

396 Tongfu Road Middle, Haizhu District

经费或物资来源:

广州市基础研究计划市校(院)企联合资助项目

Source(s) of funding:

Guangzhou Basic Research Plan Municipal University (Institute) Enterprise Joint Funding Project

研究疾病:

慢性创面  

Target disease:

Chronic wound

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.调查慢性创面患者研究前的维生素D水平; 2.描述维生素D不充足的慢性创面患者补充胆骨化醇后血清25(OH)D的提升变化; 3.比较充足维生素D水平的同期患者和维生素D处于不充足水平的患者创面愈合之间的差异,包括创面感染率、创面体积缩小率、PUSH评分、创面平均愈合天数和创面愈合有效率;  

Objectives of Study:

1. To investigate pre-study vitamin D levels in patients with chronic wounds; 2. To describe the elevation of serum 25 (OH) D after cholecalcitol supplementation in chronic wound patients; 3. Cpmpare the differences in wound healing between patients with adequate vitamin D levels and those with inadequate vitamin D levels.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.孕妇或哺乳患者;
2.癌性创面;
3.未经治疗的骨髓炎;
4.长期吸烟史或长期大量饮酒史患者;
5.过去三个月有口服主要为维生素D的补充剂。

Exclusion criteria:

1. Pregnant woman or feeding women;
2. Cancerous wounds;
3. Untreated osteomyelitis;
4. Patients with long history of smoking or heavy alcohol consumption;
5. Oral supplements, mainly vitamin D, have been available for the past three months.

研究实施时间:

Study execute time:

From 2022-11-01 00:00:00 To 2023-11-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-11-01 00:00:00 To 2023-11-01 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

30

Group:

Intervention group

Sample size:

干预措施:

服用胆骨化醇6000IU/d,8周

干预措施代码:

Intervention:

Cholecalciferol 6000 IU/d for 8 weeks

Intervention code:

组别:

同期维生素D不充足组

样本量:

30

Group:

Vitamin D deficiency group in the same period

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

广州 

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州市红十字会医院 

单位级别:

三级甲等 

Institution
hospital:

Guangzhou Red Cross Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

血清25(OH)D

指标类型:

主要指标

Outcome:

Serum 25 (OH) D

Type:

Primary indicator

测量时间点:

研究的第0周、第4周及第8周

测量方法:

抽取空腹血清样本

Measure time point of outcome:

Week 0, week 4 and week 8 of the study

Measure method:

A fasting serum sample was taken

指标中文名:

创面愈合有效率

指标类型:

主要指标

Outcome:

effective wound healing rate

Type:

Primary indicator

测量时间点:

每周

测量方法:

Measure time point of outcome:

every week

Measure method:

指标中文名:

创面体积缩小率

指标类型:

次要指标

Outcome:

wound volume reduction rate

Type:

Secondary indicator

测量时间点:

每周

测量方法:

Measure time point of outcome:

every week

Measure method:

指标中文名:

平均愈合天数

指标类型:

次要指标

Outcome:

mean healing day

Type:

Secondary indicator

测量时间点:

每周

测量方法:

Measure time point of outcome:

every week

Measure method:

指标中文名:

PUSH量表评分

指标类型:

次要指标

Outcome:

the score of pressure ulcer scale for healing (PUSH)

Type:

Secondary indicator

测量时间点:

每周

测量方法:

Measure time point of outcome:

every week

Measure method:

指标中文名:

创面感染率

指标类型:

次要指标

Outcome:

wound infection rate

Type:

Secondary indicator

测量时间点:

每周

测量方法:

Measure time point of outcome:

every week

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

静脉

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

研究员利用SAS软件随机产生一串数字形成随机数字排列区组,研究对象按照随机数字排列区组依次入组。

Randomization Procedure (please state who generates the random number sequence and by what method):

The researchers used SAS software to randomly generate a string of numbers to form a random number arrangement block, and the study subjects were successively divided into groups according to the random number arrangement block.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

预注册未有数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

预注册未有数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

none

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-11-06 11:42:29